Trifocal Intraocular Lens (IOL) Aberrometry Outcomes

Weill Cornell Medicine (WCM)

Status: Completed

Conditions: Cataract

Treatments: Device: Alcon Trifocal and Trifocal Toric Intraocular Lenses

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04196569

19-05020251

Details and patient eligibility

About

The goal of this study is to evaluate subject outcomes and spectacle independence with intraoperative aberrometry and trifocal IOL implantation.

Enrollment: 24 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Able to consent to study and cataract surgery
• Visually significant cataract
• Potential post-operative visual acuity of 20/25 or better
• Age 18 years or older

Exclusion criteria

• Ocular pathology contraindicated for trifocal IOLs including but not limited to diabetic retinopathy, age-related macular degeneration or other macular pathology, cornea guttata, corneal scarring, corneal ectasia, glaucoma with visual field loss
• Irregular astigmatism
• Prior corneal refractive surgery

Trial design

24 participants in 1 patient group

trifocal intraocular lens

Treatment:

Device: Alcon Trifocal and Trifocal Toric Intraocular Lenses